The U.S. Food and Drug Administration (FDA) has approved Ubrelvy (ubrogepant) tablets for immediate treatment of migraine with or without aura in adults. Ubrelvy is not indicated for the preventive treatment of migraine. It is the first drug in the class of oral calcitonin gene-related peptide receptor antagonists approved for the acute treatment of migraine.… Continue reading New Migraine Treatment Approved for Adults
Category: Migraine
FDA Approves New Migraine Remedy
The federal government has approved Reyvow (lasmiditan) tablets for the acute (active but short-term) treatment of migraine with or without aura in adults. Reyvow is not indicated for the preventive treatment of migraine. “Reyvow is a new option for the acute treatment of migraine, a painful condition that affects one in seven Americans,” said Nick… Continue reading FDA Approves New Migraine Remedy
How to Win The Migraine Battle
Migraines are a neurological disease that affects about 39 million men, women and children in the United States and close to one billion people worldwide. These headaches and the associated symptoms are considered among the top 10 most disabling illnesses in the world with an unknown cause. Providing relief require a breadth and depth of… Continue reading How to Win The Migraine Battle
FDA Approves Novel Preventive Treatment for Migraine
On May 17th 2018, the U.S. Food and Drug Administration approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections. Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide, a molecule that… Continue reading FDA Approves Novel Preventive Treatment for Migraine
Diet Can Impact Migraines
Eliminating that morning “Cup of Joe,” consuming processed foods high in nitrites or monosodium glutamate (MSG) and enjoying too much alcohol are potential headache triggers for people battling migraines, says Vincent Martin, MD, professor in the Department of Internal Medicine at the University of Cincinnati (UC) College of Medicine. An October 31st 2016 release from… Continue reading Diet Can Impact Migraines
Migraine Drugs Are Underused
About 38 million Americans suffer from migraines in the United States, according to the Migraine Research Foundation. The most commonly used and effective classes of medication, triptans and DHE (Dihydroergotamine), however, have a black box warning for two subtypes of migraine because of risk of stroke. Yet researchers at Abington-Jefferson Health have shown, as of… Continue reading Migraine Drugs Are Underused
Menopause and Migraines
Migraines increase as women approach menopause, according to new research. The discovery was made by investigators at the University of Cincinnati (UC), Montefiore Headache Center, Albert Einstein College of Medicine and Vedanta Research. “Women have been telling doctors that their migraine headaches worsen around menopause and now we have proof they were right,” says Vincent… Continue reading Menopause and Migraines
Solve the Medical Riddle: She Has Had a Constant Headache for Two Weeks and Her Pupils Are Not the Same Size, Third Week
Editor’s note: Welcome to our ThirdAge feature that gives you a chance to play medical sleuth as we share the details of what happened when a patient presented with a problem that stumped the physician at first. The first week of this riddle, the patient reported her symptoms to her PCP. The doctor proceeded with… Continue reading Solve the Medical Riddle: She Has Had a Constant Headache for Two Weeks and Her Pupils Are Not the Same Size, Third Week
Hope for New Migraine Prevention Drugs
Migraine researchers and clinicians are growing excited about a new class of drugs called Calcitonin Gene-Related Peptide (CGRP) monoclonal antibodies, which are showing promise in treating high-frequency episodic migraine and chronic migraine. A release from the American Headache Society quotes Peter J. Goadsby, MD, PhD, chair of the scientific program of the American Headache Society’s… Continue reading Hope for New Migraine Prevention Drugs
Weather May Cause Migraines
If you suffer from migraine headaches, you might want to blame the winds. Canadian researchers say warm winds may trigger migraines. The report appears in the Jan. 25 issue of the scientific journal Neurology.
Dr. Wernher Becker and a team of scientists at the University of Calgary studied the effects of warm westerly winds called "chinooks" on 75 migraine patients. Nearly half of the sufferers appeared to be affected by a change in the weather with the arrival of the chinook.